These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23807811)

  • 1. Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation.
    Liu AC; Zhao LX; Lou HX
    Planta Med; 2013 Jul; 79(11):971-7. PubMed ID: 23807811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats.
    Liu AC; Zhao LX; Yu SW; Lou HX
    Chin J Nat Med; 2015 Apr; 13(4):257-63. PubMed ID: 25908622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of clopidogrel in rats.
    Chen F; Yang Y; Fang C; Zhao J; Han M; Zhu Q; Bai X; Liu M; Yang G
    Xenobiotica; 2015; 45(12):1122-8. PubMed ID: 26068527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Compound Danshen Dripping Pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Chu Y; Zhang L; Wang XY; Guo JH; Guo ZX; Ma XH
    J Ethnopharmacol; 2011 Oct; 137(3):1457-61. PubMed ID: 21878380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic understanding of the effect of Dengzhan Shengmai capsule on the pharmacokinetics of clopidogrel in rats.
    Chen X; Zhao Z; Chen Y; Gou X; Zhou Z; Zhong G; Cai Y; Huang M; Jin J
    J Ethnopharmacol; 2016 Nov; 192():362-369. PubMed ID: 27459888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS; Farid NA; Li YG; Ernest CS; Payne CD; Salazar DE; Winters KJ
    Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs.
    Brainard BM; Kleine SA; Papich MG; Budsberg SC
    Am J Vet Res; 2010 Jul; 71(7):822-30. PubMed ID: 20594086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
    von Beckerath N; Taubert D; Pogatsa-Murray G; Schömig E; Kastrati A; Schömig A
    Circulation; 2005 Nov; 112(19):2946-50. PubMed ID: 16260639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.
    Cushing DJ; Souney PF; Cooper WD; Mosher GL; Adams MP; Machatha S; Zhang B; Kowey PR
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):3-8. PubMed ID: 21933229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs.
    Lee JH; Shin YJ; Oh JH; Lee YJ
    Arch Pharm Res; 2012 Oct; 35(10):1831-7. PubMed ID: 23139136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
    Vilahur G; Pena E; Padró T; Badimon L
    Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of clopidogrel.
    Caplain H; Donat F; Gaud C; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():25-8. PubMed ID: 10440419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of clopidogrel in human plasma by liquid chromatography/tandem mass spectrometry: application to a clinical pharmacokinetic study.
    Shin BS; Yoo SD
    Biomed Chromatogr; 2007 Sep; 21(9):883-9. PubMed ID: 17472221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence and pharmacokinetic/pharmacodynamic correlation of clopidogrel in healthy Thai subjects
.
    Chunsangchan M; Chariyavilaskul P; Ketchart W; Prompila N; Wittayalertpanya S
    Int J Clin Pharmacol Ther; 2017 Dec; 55(12):915-922. PubMed ID: 29092730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.
    Karaźniewicz-Łada M; Danielak D; Burchardt P; Kruszyna L; Komosa A; Lesiak M; Główka F
    Clin Pharmacokinet; 2014 Feb; 53(2):155-64. PubMed ID: 24127209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
    Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
    Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Danshen capsules on the pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
    Zhou CH; Xu M; Yu HB; Zheng XT; Zhong ZF; Zhang LT
    Food Chem Toxicol; 2018 Sep; 119():302-308. PubMed ID: 29496531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial.
    Angiolillo DJ; Welsh RC; Trenk D; Neumann FJ; Conley PB; McClure MW; Stephens G; Kochman J; Jennings LK; Gurbel PA; Wójcik J; Dabrowski M; Saucedo JF; Stumpf J; Buerke M; Broderick S; Harrington RA; Rao SV
    Circ Cardiovasc Interv; 2012 Jun; 5(3):347-56. PubMed ID: 22619259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.